Status:
UNKNOWN
[18F] Fluorocholine FCH Positron Emission Tomography (PET)/Computed Tomography (CT) for Detection of Prostate Cancer Lymph Nodes Metastases
Lead Sponsor:
Odense University Hospital
Collaborating Sponsors:
University of Southern Denmark
Conditions:
Prostate Cancer
Eligibility:
MALE
Phase:
NA
Brief Summary
The objective of this trial is to assess the value of 18F-choline PET/CT for the detection of regional lymph node metastases from prostate cancer. In addition, the investigators want to evaluate wheth...
Detailed Description
The purpose of this prospective trail is to improve the staging of patients with prostate cancer. The investigators focus on the group of patients with a newly diagnosed prostate cancer, and specifica...
Eligibility Criteria
Inclusion
- Patients with a biopsy confirmed prostate cancer who awaits curative treatment and have
- An elevated level of prostate-specific antigen PSA\>10 ng/mL (nanogram per milliliter) or/and
- A Gleason score \> 6 or/and
- A TNM staging of T3
Exclusion
- Patients who withdraw their informed consent.
- Patients who have a bone scan indicates metastatic prostate cancer.
- Patients who have a TNM stage is T4
- In the case we detect a patient having an obvious other major illness e.g. lung cancer, the patient is referred to relevant treatment. Depending on the illness the might be excluded from the study.
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2013
Estimated Enrollment :
205 Patients enrolled
Trial Details
Trial ID
NCT00670527
Start Date
January 1 2008
End Date
April 1 2013
Last Update
October 8 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Urology, Odense University Hospital
Odense, Denmark, 5000